Perpetual Investment Management’s AbbVie ABBV Stock Holding History

Perpetual Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.73M	Sell	16,900 -1,300	-7%	-$199K	0.33%	57
2022 Q3	$2.44M	Hold	18,200	–	–	0.36%	59
2022 Q2	$2.79M	Sell	18,200 -2,800	-13%	-$428K	0.41%	57
2022 Q1	$3.4M	Hold	21,000	–	–	0.43%	60
2021 Q4	$2.84M	Sell	21,000 -800	-4%	-$94.5K	0.33%	90
2021 Q3	$2.35M	Hold	21,800	–	–	0.3%	98
2021 Q2	$2.46M	Buy	21,800 +3,200	+17%	+$360K	0.35%	86
2021 Q1	$2.01M	Hold	18,600	–	–	0.33%	66
2020 Q4	$1.96M	Buy	+18,600	New	+$1.79M	0.29%	86

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perpetual Investment Management's ABBV Position: Q4 2022 in Review

Perpetual Investment Management reduced its AbbVie (ABBV) stake by 7.1% in Q4 2022, selling an estimated $199K and leaving 16,900 shares worth $2.73M. The position accounts for 0.33% of the portfolio, ranked #57.

Perpetual Investment Management first reported a position in ABBV in Q4 2020 and has held it in 9 quarters since. The position peaked at $3.4M in Q1 2022. 3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Perpetual Investment Management held 16,900 shares of AbbVie worth $2.73M as of Q4 2022.
Perpetual Investment Management sold 1,300 AbbVie shares in Q4 2022, an estimated $199K.
AbbVie made up 0.33% of Perpetual Investment Management's portfolio in Q4 2022, its #57 holding.
Perpetual Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 9 quarters since.
Perpetual Investment Management's AbbVie position peaked at $3.4M in Q1 2022.
3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.